Orna Therapeutics
Orna Therapeutics is seeking an experienced Analytical Development leader to oversee the development and management of analytical methods for RNA-based nanotherapeutics. The role involves cross-functional collaboration, team leadership, and ensuring regulatory compliance in a fast-paced biotech environment, contributing to the advancement of innovative RNA medicines.
Headquarters
Watertown, Massachusetts, United States
Company Size
51-200 employees
Founded
2019
Orna Therapeutics is a biotechnology company creating fully engineered circular RNA (oRNA) therapeutics — an entirely new class of RNA medicines. The company designs and optimizes circular RNA molecules to enable durable, high‑level protein expression for applications such as vaccines, protein replacement, and cell therapies. Orna operates a platform-driven, engineering-first approach aimed at improving RNA stability, manufacturability, and translational potential to advance next‑generation medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orna Therapeutics.
122% above the average for this role